CN115414303A - Plant massage cream capable of relaxing and nourishing body - Google Patents
Plant massage cream capable of relaxing and nourishing body Download PDFInfo
- Publication number
- CN115414303A CN115414303A CN202210758679.5A CN202210758679A CN115414303A CN 115414303 A CN115414303 A CN 115414303A CN 202210758679 A CN202210758679 A CN 202210758679A CN 115414303 A CN115414303 A CN 115414303A
- Authority
- CN
- China
- Prior art keywords
- parts
- phase
- weight
- raw materials
- following raw
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000006071 cream Substances 0.000 title claims abstract description 44
- 230000002040 relaxant effect Effects 0.000 title claims description 3
- 239000002994 raw material Substances 0.000 claims abstract description 96
- 239000000284 extract Substances 0.000 claims abstract description 45
- 241000196324 Embryophyta Species 0.000 claims abstract description 23
- 235000015112 vegetable and seed oil Nutrition 0.000 claims abstract description 17
- 235000013912 Ceratonia siliqua Nutrition 0.000 claims abstract description 8
- 240000008886 Ceratonia siliqua Species 0.000 claims abstract description 8
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 42
- TXFPEBPIARQUIG-UHFFFAOYSA-N 4'-hydroxyacetophenone Chemical compound CC(=O)C1=CC=C(O)C=C1 TXFPEBPIARQUIG-UHFFFAOYSA-N 0.000 claims description 28
- CDQSJQSWAWPGKG-UHFFFAOYSA-N butane-1,1-diol Chemical compound CCCC(O)O CDQSJQSWAWPGKG-UHFFFAOYSA-N 0.000 claims description 16
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 claims description 13
- 229960005323 phenoxyethanol Drugs 0.000 claims description 13
- 238000003756 stirring Methods 0.000 claims description 13
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 9
- 230000003020 moisturizing effect Effects 0.000 claims description 9
- 235000018330 Macadamia integrifolia Nutrition 0.000 claims description 8
- 240000000912 Macadamia tetraphylla Species 0.000 claims description 8
- 235000003800 Macadamia tetraphylla Nutrition 0.000 claims description 8
- 244000044822 Simmondsia californica Species 0.000 claims description 8
- 235000004433 Simmondsia californica Nutrition 0.000 claims description 8
- 229920000669 heparin Polymers 0.000 claims description 8
- 235000019198 oils Nutrition 0.000 claims description 8
- 238000001816 cooling Methods 0.000 claims description 7
- ZFGMDIBRIDKWMY-PASTXAENSA-N heparin Chemical compound CC(O)=N[C@@H]1[C@@H](O)[C@H](O)[C@@H](COS(O)(=O)=O)O[C@@H]1O[C@@H]1[C@@H](C(O)=O)O[C@@H](O[C@H]2[C@@H]([C@@H](OS(O)(=O)=O)[C@@H](O[C@@H]3[C@@H](OC(O)[C@H](OS(O)(=O)=O)[C@H]3O)C(O)=O)O[C@@H]2O)CS(O)(=O)=O)[C@H](O)[C@H]1O ZFGMDIBRIDKWMY-PASTXAENSA-N 0.000 claims description 7
- 229960001008 heparin sodium Drugs 0.000 claims description 7
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 claims description 6
- 238000010438 heat treatment Methods 0.000 claims description 6
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 claims description 6
- 229940015975 1,2-hexanediol Drugs 0.000 claims description 5
- VLDFMKOUUQYFGF-UHFFFAOYSA-N 4-(butoxymethyl)-2-methoxyphenol Chemical compound CCCCOCC1=CC=C(O)C(OC)=C1 VLDFMKOUUQYFGF-UHFFFAOYSA-N 0.000 claims description 5
- 239000004475 Arginine Substances 0.000 claims description 5
- 241001165494 Rhodiola Species 0.000 claims description 5
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims description 5
- FHKSXSQHXQEMOK-UHFFFAOYSA-N hexane-1,2-diol Chemical compound CCCCC(O)CO FHKSXSQHXQEMOK-UHFFFAOYSA-N 0.000 claims description 5
- 229940078465 vanillyl butyl ether Drugs 0.000 claims description 5
- 229940081733 cetearyl alcohol Drugs 0.000 claims description 4
- 239000000498 cooling water Substances 0.000 claims description 4
- IUMSDRXLFWAGNT-UHFFFAOYSA-N Dodecamethylcyclohexasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 IUMSDRXLFWAGNT-UHFFFAOYSA-N 0.000 claims description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 3
- 235000018167 Reynoutria japonica Nutrition 0.000 claims description 3
- 240000001341 Reynoutria japonica Species 0.000 claims description 3
- 235000017089 Scutellaria baicalensis Nutrition 0.000 claims description 3
- 240000004534 Scutellaria baicalensis Species 0.000 claims description 3
- 244000269722 Thea sinensis Species 0.000 claims description 3
- 150000001720 carbohydrates Chemical class 0.000 claims description 3
- 229940059958 centella asiatica extract Drugs 0.000 claims description 3
- 239000008103 glucose Substances 0.000 claims description 3
- 229930182478 glucoside Natural products 0.000 claims description 3
- 150000008131 glucosides Chemical class 0.000 claims description 3
- 239000001947 glycyrrhiza glabra rhizome/root Substances 0.000 claims description 3
- 229940100460 peg-100 stearate Drugs 0.000 claims description 3
- 238000005086 pumping Methods 0.000 claims description 3
- 239000001331 rosmarinus officinalis leaf Substances 0.000 claims description 3
- 238000005070 sampling Methods 0.000 claims description 3
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 claims description 3
- 235000010234 sodium benzoate Nutrition 0.000 claims description 3
- 239000004299 sodium benzoate Substances 0.000 claims description 3
- 235000009436 Actinidia deliciosa Nutrition 0.000 claims description 2
- 244000298697 Actinidia deliciosa Species 0.000 claims description 2
- 235000007866 Chamaemelum nobile Nutrition 0.000 claims description 2
- 235000007232 Matricaria chamomilla Nutrition 0.000 claims description 2
- 238000001914 filtration Methods 0.000 claims description 2
- 238000002360 preparation method Methods 0.000 claims description 2
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 claims 1
- 244000042664 Matricaria chamomilla Species 0.000 claims 1
- 210000003491 skin Anatomy 0.000 abstract description 26
- 230000000694 effects Effects 0.000 abstract description 11
- 230000017531 blood circulation Effects 0.000 abstract description 5
- 102000004190 Enzymes Human genes 0.000 abstract description 4
- 108090000790 Enzymes Proteins 0.000 abstract description 4
- 235000010627 Phaseolus vulgaris Nutrition 0.000 abstract description 4
- 244000046052 Phaseolus vulgaris Species 0.000 abstract description 4
- 239000000126 substance Substances 0.000 abstract description 4
- 239000008158 vegetable oil Substances 0.000 abstract description 4
- 235000003713 Rhodiola rosea Nutrition 0.000 abstract description 2
- 244000042430 Rhodiola rosea Species 0.000 abstract description 2
- 235000015097 nutrients Nutrition 0.000 abstract description 2
- 210000004927 skin cell Anatomy 0.000 abstract description 2
- 239000003921 oil Substances 0.000 description 7
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 6
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 5
- 239000002537 cosmetic Substances 0.000 description 5
- 239000005556 hormone Substances 0.000 description 4
- 229940088597 hormone Drugs 0.000 description 4
- 230000035946 sexual desire Effects 0.000 description 4
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 3
- LXAHHHIGZXPRKQ-UHFFFAOYSA-N 5-fluoro-2-methylpyridine Chemical compound CC1=CC=C(F)C=N1 LXAHHHIGZXPRKQ-UHFFFAOYSA-N 0.000 description 3
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 3
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 3
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- KWIUHFFTVRNATP-UHFFFAOYSA-O N,N,N-trimethylglycinium Chemical compound C[N+](C)(C)CC(O)=O KWIUHFFTVRNATP-UHFFFAOYSA-O 0.000 description 3
- OQILCOQZDHPEAZ-UHFFFAOYSA-N Palmitinsaeure-octylester Natural products CCCCCCCCCCCCCCCC(=O)OCCCCCCCC OQILCOQZDHPEAZ-UHFFFAOYSA-N 0.000 description 3
- 229920002385 Sodium hyaluronate Polymers 0.000 description 3
- 229920002125 Sokalan® Polymers 0.000 description 3
- 235000018936 Vitellaria paradoxa Nutrition 0.000 description 3
- 241001135917 Vitellaria paradoxa Species 0.000 description 3
- 229960003237 betaine Drugs 0.000 description 3
- 229960001631 carbomer Drugs 0.000 description 3
- GJQLBGWSDGMZKM-UHFFFAOYSA-N ethylhexyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(CC)CCCCC GJQLBGWSDGMZKM-UHFFFAOYSA-N 0.000 description 3
- 235000008524 evening primrose extract Nutrition 0.000 description 3
- 229940089020 evening primrose oil Drugs 0.000 description 3
- 239000010475 evening primrose oil Substances 0.000 description 3
- 230000036651 mood Effects 0.000 description 3
- 210000003205 muscle Anatomy 0.000 description 3
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 3
- 239000010466 nut oil Substances 0.000 description 3
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 3
- 229940057910 shea butter Drugs 0.000 description 3
- 229940010747 sodium hyaluronate Drugs 0.000 description 3
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 3
- 229940032094 squalane Drugs 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- LADGBHLMCUINGV-UHFFFAOYSA-N tricaprin Chemical compound CCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCC)COC(=O)CCCCCCCCC LADGBHLMCUINGV-UHFFFAOYSA-N 0.000 description 3
- 206010020751 Hypersensitivity Diseases 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 229930003427 Vitamin E Natural products 0.000 description 2
- 208000026935 allergic disease Diseases 0.000 description 2
- 230000007815 allergy Effects 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 229940082500 cetostearyl alcohol Drugs 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 238000004090 dissolution Methods 0.000 description 2
- VYFYYTLLBUKUHU-UHFFFAOYSA-N dopamine Chemical compound NCCC1=CC=C(O)C(O)=C1 VYFYYTLLBUKUHU-UHFFFAOYSA-N 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 2
- FOYKKGHVWRFIBD-UHFFFAOYSA-N gamma-tocopherol acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 FOYKKGHVWRFIBD-UHFFFAOYSA-N 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 230000007794 irritation Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- YPFDHNVEDLHUCE-UHFFFAOYSA-N propane-1,3-diol Chemical compound OCCCO YPFDHNVEDLHUCE-UHFFFAOYSA-N 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 description 2
- 235000019165 vitamin E Nutrition 0.000 description 2
- 239000011709 vitamin E Substances 0.000 description 2
- 229940046009 vitamin E Drugs 0.000 description 2
- 230000037303 wrinkles Effects 0.000 description 2
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 1
- ANZUDYZHSVGBRF-UHFFFAOYSA-N 3-ethylnonane-1,2,3-triol Chemical compound CCCCCCC(O)(CC)C(O)CO ANZUDYZHSVGBRF-UHFFFAOYSA-N 0.000 description 1
- 235000016416 Actinidia arguta Nutrition 0.000 description 1
- 244000298800 Actinidia arguta Species 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 240000003538 Chamaemelum nobile Species 0.000 description 1
- 208000032544 Cicatrix Diseases 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 240000008067 Cucumis sativus Species 0.000 description 1
- 235000010799 Cucumis sativus var sativus Nutrition 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 244000281702 Dioscorea villosa Species 0.000 description 1
- 235000000504 Dioscorea villosa Nutrition 0.000 description 1
- 239000009429 Ginkgo biloba extract Substances 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 229920002683 Glycosaminoglycan Polymers 0.000 description 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
- 241000112528 Ligusticum striatum Species 0.000 description 1
- 240000002853 Nelumbo nucifera Species 0.000 description 1
- 235000006508 Nelumbo nucifera Nutrition 0.000 description 1
- 235000006510 Nelumbo pentapetala Nutrition 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 235000010575 Pueraria lobata Nutrition 0.000 description 1
- 244000046146 Pueraria lobata Species 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- 206010042496 Sunburn Diseases 0.000 description 1
- 206010043417 Therapeutic response unexpected Diseases 0.000 description 1
- 241000347391 Umbrina cirrosa Species 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 235000014104 aloe vera supplement Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 210000001217 buttock Anatomy 0.000 description 1
- 229940119217 chamomile extract Drugs 0.000 description 1
- 235000020221 chamomile extract Nutrition 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 229960003638 dopamine Drugs 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 239000003974 emollient agent Substances 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 229940068052 ginkgo biloba extract Drugs 0.000 description 1
- 235000020686 ginkgo biloba extract Nutrition 0.000 description 1
- 229940107131 ginseng root Drugs 0.000 description 1
- 210000002149 gonad Anatomy 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000007407 health benefit Effects 0.000 description 1
- 229960002897 heparin Drugs 0.000 description 1
- 239000002085 irritant Substances 0.000 description 1
- 231100000021 irritant Toxicity 0.000 description 1
- GOMNOOKGLZYEJT-UHFFFAOYSA-N isoflavone Chemical compound C=1OC2=CC=CC=C2C(=O)C=1C1=CC=CC=C1 GOMNOOKGLZYEJT-UHFFFAOYSA-N 0.000 description 1
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 description 1
- 235000008696 isoflavones Nutrition 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 230000008338 local blood flow Effects 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 230000003278 mimic effect Effects 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 235000021281 monounsaturated fatty acids Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 125000002801 octanoyl group Chemical group C(CCCCCCC)(=O)* 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 239000003016 pheromone Substances 0.000 description 1
- -1 polyethylene Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229940064064 purslane extract Drugs 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 229940094944 saccharide isomerate Drugs 0.000 description 1
- 210000004761 scalp Anatomy 0.000 description 1
- 231100000241 scar Toxicity 0.000 description 1
- 230000037387 scars Effects 0.000 description 1
- 210000002374 sebum Anatomy 0.000 description 1
- 229940082941 sedum roseum root extract Drugs 0.000 description 1
- 239000002884 skin cream Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- 230000008728 vascular permeability Effects 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 210000003905 vulva Anatomy 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 239000001243 zingiber officinale rosc. root absolute Substances 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9794—Liliopsida [monocotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/592—Mixtures of compounds complementing their respective functions
- A61K2800/5922—At least two compounds being classified in the same subclass of A61K8/18
Abstract
The invention discloses a plant massage cream for soothing and nourishing bodies, which comprises the following raw materials in parts by weight: 57.4-67.76 parts of P1 phase, 25.8-31.1 parts of P2 phase, 1.16-1.2 parts of P3 phase, 3.9-8.6 parts of P4 phase, 1.35-1.75 parts of P5 phase and 0.01-0.05 part of P6 phase; the invention perfectly combines a pure natural plant formula with modern biotechnology, and specially contains natural active enzyme components extracted from carob bean fruit extract, rhodiola rosea extract and the like to be compounded with vegetable oil, and through simple smearing and massage, various plant active components and various nutrient substances are acted on body tissues in 360 degrees without dead angles, so that the skin is directly permeated and quickly absorbed, the blood circulation of the skin is deeply improved, the activity of skin cells is comprehensively nourished, the blood circulation is promoted, and the body skin is effectively relaxed in a short time to make the mind pleasant.
Description
Technical Field
The invention relates to the technical field of skin care products, in particular to a plant massage cream for soothing and nourishing bodies.
Background
Cosmetics such as body massage cream were investigated: many massage cream products on the market have the phenomenon of muddy water and fish touching, and cannot achieve the effect of really delightfully nourishing the body;
at present, common oil is low in price and is generally used in cosmetics such as skin cream, however, the common oil has poor moisturizing and absorbing performance on skin and low safety. At present, the consumption concepts of environmental protection, safety and no public harm are increasingly deeply focused on people, along with the continuous completion of cosmetic technology and laws and regulations, the safety requirements on cosmetics such as body massage cream are higher and higher, and the safe, mild, non-irritant and good-effect massage cream represents the development direction of the future skin-care massage cream, and the traditional massage cream adopting mineral oil is difficult to meet the requirements.
Disclosure of Invention
The invention aims to solve the problems of the background technology and provides a plant massage cream for body comfort and nourishing; the natural active enzyme compound vegetable oil is prepared by perfectly combining a pure natural plant formula with modern biotechnology, specially contains natural active enzyme components extracted from carob bean fruit extract, rhodiola rosea extract and the like and is compounded with vegetable oil, and various plant active components and various nutrient substances are acted on body tissues in a 360-degree dead angle-free manner through simple smearing and massage, so that the natural active enzyme compound vegetable oil is directly permeated and quickly absorbed, the blood circulation of skin is deeply improved, the activity of skin cells is comprehensively nourished, the blood circulation is promoted, and the body skin is effectively relaxed in a short time to make the mood pleasant.
The purpose of the invention can be realized by the following technical scheme:
a plant massage cream for soothing and nourishing bodies comprises the following raw materials in parts by weight: 57.4-67.76 parts of P1 phase, 25.8-31.1 parts of P2 phase, 1.16-1.2 parts of P3 phase, 3.9-8.6 parts of P4 phase, 1.35-1.75 parts of P5 phase and 0.01-0.05 part of P6 phase;
the P1 phase comprises the following raw materials in parts by weight: 0.001-0.2 parts of heparin sodium:
the P2 phase comprises the following raw materials in parts by weight: 0.12-0.5 part of jojoba seed oil and 0.12-0.5 part of macadamia nut seed oil;
the P3 phase comprises the following raw materials in parts by weight: 0.16-0.2 part of arginine and 1 part of water;
the P4 phase comprises the following raw materials in parts by weight: 0.03-0.1 part of vanillyl butyl ether;
the P5 phase comprises the following raw materials in parts by weight: 0.5-0.7 part of p-hydroxyacetophenone and 0.3-0.5 part of 1, 2-hexanediol;
the P6 phase comprises the following raw materials in parts by weight: 0.01-0.05 part of essence;
the preparation process of the moisturizing massage cream comprises the following steps:
step 1: adding a P1 phase into the host machine, and completely dispersing; heating to 82-85 deg.C, stirring and dissolving;
step 2: adding P2 phase into oil phase pot, heating to 78-82 deg.C for dissolving;
and step 3: vacuumizing a main machine, pumping the P2 phase into the P1 phase, homogenizing for 5-8 minutes, stirring and dissolving completely, preserving heat for 15-20 minutes, and defoaming;
and 4, step 4: cooling to 64-66 deg.C, sequentially adding pre-dissolved P3 phase, stirring, and continuously cooling;
and 5: cooling to below 45 deg.C, sequentially adding P4 and P5 phases, adding P6 phase, and stirring;
step 6: sampling and detecting, after the product is qualified, closing the cooling water at 38-40 ℃, and filtering to obtain the moisturizing massage cream.
As a further scheme of the invention: the P2 phase also comprises the following raw materials in parts by weight: p21 parts;
the P21 comprises the following raw materials in percentage by weight: cetearyl alcohol 80%, cetearyl glucoside 19.6%, water 0.1%, glucose 0.3%.
As a further scheme of the invention: the P2 phase also comprises the following raw materials in parts by weight: 0.8-1.5 parts of P22;
p22 comprises the following raw materials in percentage by weight: 65% of glycerol stearate and 35% of PEG-100 stearate.
As a further scheme of the invention: the P2 phase also comprises the following raw materials in parts by weight: 1-3 parts of P23;
p23 comprises the following raw materials in percentage by weight: 70% of cyclopentadimethicone and 30% of cyclohexasiloxane.
As a further scheme of the invention: the P4 phase also comprises the following raw materials in parts by weight: 0.3-0.5 part of P41;
the P41 comprises the following raw materials in percentage by weight: 98.4% of water, 0.9% of saccharide isomer, 0.6% of sodium benzoate and 0.1% of citric acid.
As a further scheme of the invention: the P4 phase also comprises the following raw materials in parts by weight: 0.3 part of P42;
the P42 comprises the following raw materials in percentage by weight: 96.6% of water, 3% of actinidia arguta extract and 0.4% of phenoxyethanol.
As a further scheme of the invention: the P4 phase also comprises the following raw materials in parts by weight: 2-5 parts of P43;
the P43 comprises the following raw materials in percentage by weight: 3.5 percent of rhodiola root extract, 10 percent of butanediol, 0.5 percent of p-hydroxyacetophenone and 86 percent of water.
As a further scheme of the invention: the P4 phase also comprises the following raw materials in parts by weight: 0.1-1 part of P44;
p44 comprises the following raw materials in percentage by weight: 3.5 percent of maigre fanghua extract, 10 percent of butanediol, 0.5 percent of p-hydroxyacetophenone and 86 percent of water.
As a further scheme of the invention: the P4 phase also comprises the following raw materials in parts by weight: 0.1-1 part of P45;
the P45 comprises the following raw materials in percentage by weight: 3.5 percent of carob fruit extract, 10 percent of butanediol, 86 percent of water and 0.5 percent of p-hydroxyacetophenone.
As a further scheme of the invention: the P4 phase also comprises the following raw materials in parts by weight: 0.15-0.5 part of P46;
p46 comprises the following raw materials in percentage by weight: 50% of butanediol, 38% of water, 5% of centella asiatica extract, 2% of polygonum cuspidatum root extract, 2% of scutellaria baicalensis root extract, 1% of tea extract, 1% of glycyrrhiza glabra root extract, 0.5% of chamomile flower extract and 0.5% of rosemary leaf extract.
The invention has the beneficial effects that:
carob fruit extract: the natural attractiveness derived from pheromone;
rhodiola root extract: it induces the biosynthesis of beta-endorphins by stimulating central and peripheral receptors, thereby improving the general mood and body, and providing relaxation, stress resistance and health benefits when applied to the skin and hair;
long mollissima root extract: contains multiple aglycones, dopamine, multiple alkaloids, multiple amino acids, and multiple sterols; has effects in relieving skin allergy, killing bacteria, and relieving inflammation;
saccharide isomerate: improving blood circulation, revitalizing health and good complexion, making light-emitting muscles, luxurious and beautiful youth, emitting red light and moistening muscles, revitalizing the red light and the glowing muscles, optimistically, confidently and pleasantly calling, beautifying and maintaining beauty, and relieving pressure and anxiety
Heparin sodium: is an acidic mucopolysaccharide substance, and has effects in resisting blood coagulation, resisting thrombi, relieving inflammation, regulating blood lipid and reducing blood viscosity. The application of heparin in skin care is a hot point of cosmetics in recent years, and has the effects of increasing the vascular permeability of the skin and improving local blood circulation; the heparin sodium promotes the supply of skin nutrition and the excretion of metabolic waste, and plays a good role in health care and maintenance of the skin;
macadamia nut seed oil; macadamia nut oil reduces wrinkles and dryness. It is a natural moisturizing and soothing substance (the emollient attracts and traps moisture from the air). Macadamia nut oil is light and non-greasy in texture and is easily absorbed into hair and skin. It contains protein, vitamin E and skin care effect, and has long shelf life. The high count of monounsaturated fatty acids makes the oil mimic sebum (naturally occurring oils can protect it from damage on the scalp and skin). All these qualities contribute to its reputation as an excellent treatment of hair and skin, as well as healing scars, fagodon sunburn, wounds and irritations.
Jojoba seed oil: contains abundant vitamin D and protein, is good moisturizing and moisturizing oil, can maintain skin moisture, prevent wrinkles and soften skin, is suitable for mature and aged skin, and is commonly used for face and body massage and hair care;
in conclusion, the massage cream provided by the invention is obviously commented on the problems of pleasant mood and body moistening, and all subjects like to use the endowment cream, so that the product is safe and mild without allergy, and 80% of the subjects can continue to use the cream regularly after two weeks; the body skin is moistened and glossy by using the endowment cream, the cream is quickly absorbed without being sticky, the added carob bean fruit extract, the rhodiola root extract, the jojoba seed oil and the like can quickly relax the body after massage, make the mind pleasant and stimulate the effect of hormone on enhancing sexual desire, and the endowment cream can effectively make the mind pleasant and stimulate the effect of hormone on enhancing sexual desire to ensure that the skin is moist, smooth and elastic.
Detailed Description
The technical solutions in the embodiments of the present invention will be clearly and completely described below with reference to the embodiments of the present invention, and it is obvious that the described embodiments are only a part of the embodiments of the present invention, and not all of the embodiments. All other embodiments, which can be derived by a person skilled in the art from the embodiments given herein without making any creative effort, shall fall within the protection scope of the present invention.
Example 1
The invention relates to a plant massage cream for soothing and nourishing bodies, which comprises the following raw materials in parts by weight: 57.4 Parts of a P1 phase, 25.8 parts of a P2 phase, 1.16 parts of a P3 phase, 3.9 parts of a P4 phase, 1.35 parts of a P5 phase and 0.01 part of a P6 phase;
wherein the P1 phase comprises the following raw materials in parts by weight: 46.4800 parts of water, 0.001 part of sodium hyaluronate, 0.16 part of carbomer, 0.02 part of EDTA disodium, 0.5 part of betaine, 3 parts of butanediol, 0.001 part of heparin sodium, 1.5 parts of P11, 0.05 part of P12, 0.05 part of P13, 0.05 part of P14, 0.05 part of P15, 0.05 part of P16, 0.02 part of P17, 0.1 part of P18, 0.05 part of P19, 0.05 part of P110, 0.05 part of P111 and 0.05 part of P112;
p11 comprises the following raw materials in percentage by weight: 99.5 percent of glycerol polyether-26 and 0.5 percent of water;
p12 comprises the following raw materials in percentage by weight: 96.6 percent of water, 3.0 percent of ginger root extract and 0.4 percent of phenoxyethanol;
p13 comprises the following raw materials in percentage by weight: 96.6% of water, 3% of aloe vera extract and 0.4% of phenoxyethanol;
p14 comprises the following raw materials in percentage by weight: 96.5% of water, 3% of ginseng root extract and 0.5% of phenoxyethanol;
p15 comprises the following raw materials in percentage by weight: 96.6% of water, 3% of collagen and 0.4% of phenoxyethanol;
p16 comprises the following raw materials in percentage by weight: 96.6% of water, 3% of cucumber extract and 0.4% of phenoxyethanol;
p17 comprises the following raw materials in percentage by weight: soybean isoflavone 10%, polyethylene glycol-4%;
the P18 comprises the following raw materials in percentage by weight: 96.5% of water, 3.0% of kudzu root extract and 0.5% of phenoxyethanol;
p19 comprises the following raw materials in percentage by weight: water 13%, butylene glycol (85%, dioscorea villosa root extract 2%;
the P110 comprises the following raw materials in percentage by weight: 96% of water, 3.6% of snow lotus herb extract and 0.4% of phenoxyethanol;
p111 comprises the following raw materials in percentage by weight: 95% of water, 4.6% of ligusticum wallichii extract and 0.4% of phenoxyethanol;
p112 comprises the following raw materials in percentage by weight: 96.4% of water, 3.2% of ginkgo biloba extract and 0.4% of phenoxyethanol;
the P2 phase comprises the following raw materials in parts by weight: 2 parts of P21, 0.8 part of P22, 1.6 parts of cetostearyl alcohol, 0.12 part of jojoba seed oil, 1 part of evening primrose oil, 1 part of P23, 2 parts of caprylic/capric triglyceride, 0.2 part of shea butter, 5 parts of isopropyl myristate, 8 parts of ethylhexyl palmitate, 2 parts of squalane, 0.12 part of macadamia nut seed oil and 0.12 part of tocopheryl acetate;
the P21 comprises the following raw materials in percentage by weight: cetearyl alcohol 80%, cetearyl glucoside 19.6%, water 0.1%, glucose 0.3%;
the P22 comprises the following raw materials in percentage by weight: 65% of glycerol stearate and 35% of PEG-100 stearate;
the P23 comprises the following raw materials in percentage by weight: 70% of cyclopentadimethicone and 30% of cyclohexasiloxane;
the P3 phase comprises the following raw materials in parts by weight: 0.16 part of arginine and 1 part of water;
the P4 phase comprises the following raw materials in parts by weight: 0.03 part of vanillyl butyl ether, 0.3 part of P41, 0.3 part of P42, 2 parts of P43, 0.1 part of P44, 0.1 part of P45, 0.15 part of P46 and 0.2 part of P47;
the P41 comprises the following raw materials in percentage by weight: 98.4% of water, 0.9% of saccharide isomer, 0.6% of sodium benzoate and 0.1% of citric acid;
p42 comprises the following raw materials in percentage by weight: 96.6% of water, 3% of a kiwifruit spiny extract and 0.4% of phenoxyethanol;
the P43 comprises the following raw materials in percentage by weight: 3.5 percent of rhodiola root extract, 10 percent of butanediol, 0.5 percent of p-hydroxyacetophenone and 86 percent of water;
p44 comprises the following raw materials in percentage by weight: 3.5% of an extract of the vegetarian fanghua, 10% of butanediol, 0.5% of p-hydroxyacetophenone and 86% of water;
p45 comprises the following raw materials in percentage by weight: 3.5 percent of carob fruit extract, 10 percent of butanediol, 86 percent of water and 0.5 percent of p-hydroxyacetophenone;
p46 comprises the following raw materials in percentage by weight: 50% of butanediol, 38% of water, 5% of centella asiatica extract, 2% of polygonum cuspidatum root extract, 2% of scutellaria baicalensis root extract, 1% of tea extract, 1% of glycyrrhiza glabra root extract, 0.5% of chamomile extract and 0.5% of rosemary leaf extract;
the P47 comprises the following raw materials in percentage by weight: 78.4% of water, 20% of butanediol, 1% of purslane extract and 0.6% of phenoxyethanol;
the P5 phase comprises the following raw materials in parts by weight: 0.5 part of P-hydroxyacetophenone, 0.3 part of 1, 2-hexanediol, 0.05 part of P51 and 0.5 part of P52;
the P51 comprises the following raw materials in percentage by weight: 99.9% of ethylhexyl glycerol and 0.1% of tocopherol vitamin E;
the P52 comprises the following raw materials in percentage by weight: 92.5% of 1, 3-propylene glycol and 7.5% of caprylyl hydroximic acid;
the P6 phase comprises the following raw materials in parts by weight: 0.01 part of essence.
Example 2
The difference from the embodiment 1 is that:
a plant massage cream for soothing and nourishing bodies comprises the following raw materials in parts by weight: 60.76 parts of P1 phase, 28.1 parts of P2 phase, 1.18 parts of P3 phase, 5.9 parts of P4 phase, 1.55 parts of P5 phase and 0.03 part of P6 phase;
wherein the P1 phase comprises the following raw materials in parts by weight: 53.6000 parts of water, 0.05 part of sodium hyaluronate, 0.18 part of carbomer, 0.05 part of EDTA disodium, 1 part of betaine, 3 parts of butanediol, 0.2 part of heparin sodium, 2 parts of P, 0.1 part of P12, 0.2 part of P13, 0.2 part of P14, 0.2 part of P15, 0.2 part of P16, 0.3 part of P17, 0.5 part of P18, 0.2 part of P19, 0.2 part of P110, 0.2 part of P111 and 0.2 part of P112;
the P2 phase comprises the following raw materials in parts by weight: 2 parts of P21, 1.2 parts of P22, 1.8 parts of cetostearyl alcohol, 0.5 part of jojoba seed oil, 1.5 parts of evening primrose oil, 2.5 parts of P23, 2 parts of caprylic/capric triglyceride, 0.5 part of shea butter, 5 parts of isopropyl myristate, 8 parts of ethylhexyl palmitate, 1 part of squalane, 0.3 part of macadamia nut oil and 0.18 part of tocopheryl acetate;
the P3 phase comprises the following raw materials in parts by weight: 0.18 part of arginine and 1 part of water;
the P4 phase comprises the following raw materials in parts by weight: 0.08 part of vanillyl butyl ether, 0.3 part of P41, 0.3 part of P42, 3 parts of P43, 0.5 part of P44, 0.5 part of P45, 0.3 part of P46 and 0.2 part of P47;
the P5 phase comprises the following raw materials in parts by weight: 0.7 part of P-hydroxyacetophenone, 0.5 part of 1, 2-hexanediol, 0.05 part of P51 and 0.5 part of P52;
the P6 phase comprises the following raw materials in parts by weight: 0.01 part of essence.
Example 3
The difference from the example 1 is that:
a plant massage cream for soothing and nourishing bodies comprises the following raw materials in parts by weight: 67.76 parts of P1 phase, 31.1 parts of P2 phase, 1.2 parts of P3 phase, 8.6 parts of P4 phase, 1.75 parts of P5 phase and 0.05 part of P6 phase;
wherein the P1 phase comprises the following raw materials in parts by weight: 61.4280 parts of water, 0.005 part of sodium hyaluronate, 0.2 part of carbomer, 0.05 part of EDTA disodium, 2 parts of betaine, 3 parts of butanediol, 0.2 part of heparin sodium, 3 parts of P11, 0.3 part of P12, 0.1 part of P13, 0.3 part of P14, 0.3 part of P15, 0.3 part of P16, 0.02-0.3 part of P17, 2 parts of P18, 0.3 part of P19, 0.3 part of P110, 0.3 part of P111 and 0.3 part of P112;
the P2 phase comprises the following raw materials in parts by weight: 2 parts of P21, 1.5 parts of P22, 1.6-2 parts of cetearyl alcohol, 0.5 part of jojoba seed oil, 2 parts of evening primrose oil, 3 parts of P23, 2 parts of caprylic/capric triglyceride, 0.6 part of shea butter, 5 parts of isopropyl myristate, 8 parts of ethylhexyl palmitate, 3 parts of squalane, 0.5 part of macadamia nut seed oil and 0.5 part of tocopherol acetate;
the P3 phase comprises the following raw materials in parts by weight: 0.2 part of arginine and 1 part of water;
the P4 phase comprises the following raw materials in parts by weight: 0.1 part of vanillyl butyl ether, 0.5 part of P41, 0.3 part of P42, 5 parts of P43, 1 part of P44, 1 part of P45, 0.5 part of P46 and 0.2 part of P47;
the P5 phase comprises the following raw materials in parts by weight: 0.7 part of P-hydroxyacetophenone, 0.5 part of 1, 2-hexanediol, 0.05 part of P51 and 0.5 part of P52;
the P6 phase comprises the following raw materials in parts by weight: 0.05 part of essence.
Example 4
A production process of a plant massage cream for relaxing and nourishing bodies comprises the following steps: the method comprises the following steps:
step 1: cleaning and sterilizing production equipment, tools and containers; adding a P1 phase into the host machine, and completely dispersing; heating to 82-85 deg.C, stirring and dissolving completely;
and 2, step: adding P2 phase into oil phase pot, heating to 78-82 deg.C to dissolve completely;
and step 3: vacuumizing a main machine, adjusting the stirring speed, pumping the P2 phase into the P1 phase, homogenizing for 5-8 minutes, stirring for complete dissolution, preserving heat for 15-20 minutes, and defoaming;
and 4, step 4: boiling cooling water, cooling to 64-66 deg.C, sequentially adding pre-dissolved P3 phase, stirring, and continuously cooling;
and 5: cooling to below 45 deg.C, sequentially adding P4 and P5 phases (heated to 60 deg.C for complete dissolution), adding P6 phase, and stirring;
and 6: sampling and detecting, after the skin is qualified, closing the cooling water when the skin is at 38-40 ℃, discharging through a 100-mesh filter screen, and standing to obtain the moisturizing massage cream.
Examples of the experiments
100 office workers (100 women, age 25-50 years) were selected for the test, and the massage creams of examples 1 to 4 were used for the test of 100 subjects, respectively. The testee applies massage cream to vulva, gonad and buttocks every night until absorption; the massage cream is continuously used for four weeks, the testees score the skin effect according to the feelings of the testees, the scoring adopts 5 points, 1 point is the worst, 3 points are moderate, 5 points are the best, the higher the scoring is, the better the effect is, the scoring of 100 testees is 1-2 points before use, and the evaluation results of the effect after use are as follows:
| examples | Moistening degree | Q elasticity | Irritation property | Pleasure feeling | Results |
| 1 | 4 | 3 | 3 | 2 | 3 |
| 2 | 5 | 4 | 4 | 3 | 4 |
| 3 | 3 | 3 | 3 | 2 | 2.75 |
| 4 | 4 | 3 | 4 | 3 | 3.5 |
The test results in the table show that the massage cream provided by the invention has obvious favorable evaluation on pleasure and body moistening, and all the subjects like to use the massage cream, so that the product is safe and mild without allergy, and 80% of the subjects continue to use regularly after two weeks; the massage cream has the advantages that the skin of a body is moist and glossy, the skin can be quickly absorbed and is not sticky, the added carob bean fruit extract, the rhodiola rosea root extract, the jojoba seed oil and the like can quickly relax the body after massage, make people happy, and stimulate hormones to enhance the sexual desire, and the massage cream can effectively make people happy, stimulate the hormones to enhance the sexual desire, so that the skin is moist, smooth and elastic.
Although one embodiment of the present invention has been described in detail, the description is only for the purpose of illustrating the preferred embodiments of the present invention and should not be taken as limiting the scope of the invention. All equivalent changes and modifications made within the scope of the present invention shall fall within the scope of the present invention.
Claims (10)
1. The plant massage cream for relaxing and nourishing the body is characterized by comprising the following raw materials in parts by weight: 57.4-67.76 parts of P1 phase, 25.8-31.1 parts of P2 phase, 1.16-1.2 parts of P3 phase, 3.9-8.6 parts of P4 phase, 1.35-1.75 parts of P5 phase and 0.01-0.05 part of P6 phase;
the P1 phase comprises the following raw materials in parts by weight: 0.001-0.2 part of heparin sodium:
the P2 phase comprises the following raw materials in parts by weight: 0.12-0.5 part of jojoba seed oil and 0.12-0.5 part of macadamia nut seed oil;
the P3 phase comprises the following raw materials in parts by weight: 0.16-0.2 part of arginine and 1 part of water;
the P4 phase comprises the following raw materials in parts by weight: 0.03-0.1 part of vanillyl butyl ether;
the P5 phase comprises the following raw materials in parts by weight: 0.5-0.7 part of p-hydroxyacetophenone and 0.3-0.5 part of 1, 2-hexanediol;
the P6 phase comprises the following raw materials in parts by weight: 0.01-0.05 part of essence;
the preparation process of the moisturizing massage cream comprises the following steps:
step 1: adding a P1 phase into the host machine, and completely dispersing; heating to 82-85 deg.C, stirring for dissolving;
and 2, step: adding P2 phase into oil phase pot, heating to 78-82 deg.C for dissolving;
and 3, step 3: vacuumizing a main machine, pumping a P2 phase into a P1 phase, homogenizing for 5-8 minutes, stirring and dissolving completely, preserving heat for 15-20 minutes, and defoaming;
and 4, step 4: when the temperature is reduced to 64-66 ℃, adding the pre-dissolved P3 phase in sequence, stirring uniformly, and continuously reducing the temperature;
and 5: cooling to below 45 deg.C, sequentially adding P4 and P5 phases, adding P6 phase, and stirring;
step 6: and after sampling and detecting are qualified, closing the cooling water at 38-40 ℃, and filtering to obtain the moisturizing massage cream.
2. The plant massage cream for soothing and nourishing bodies as claimed in claim 1, wherein the P2 phase further comprises the following raw materials in parts by weight: p21 parts;
the P21 comprises the following raw materials in percentage by weight: cetearyl alcohol 80%, cetearyl glucoside 19.6%, water 0.1%, glucose 0.3%.
3. The plant massage cream for soothing and nourishing bodies as claimed in claim 1, wherein the P2 phase further comprises the following raw materials in parts by weight: 0.8-1.5 parts of P22;
the P22 comprises the following raw materials in percentage by weight: 65% of glycerol stearate and 35% of PEG-100 stearate.
4. The plant massage cream for soothing and nourishing bodies according to claim 1, wherein the P2 phase further comprises the following raw materials in parts by weight: 1-3 parts of P23;
the P23 comprises the following raw materials in percentage by weight: 70% of cyclopentasiloxane and 30% of cyclohexasiloxane.
5. The plant massage cream for soothing and nourishing bodies according to claim 1, wherein the P4 phase further comprises the following raw materials in parts by weight: 0.3-0.5 part of P41;
the P41 comprises the following raw materials in percentage by weight: 98.4% of water, 0.9% of saccharide isomer, 0.6% of sodium benzoate and 0.1% of citric acid.
6. The plant massage cream for soothing and nourishing bodies according to claim 1, wherein the P4 phase further comprises the following raw materials in parts by weight: 0.3 part of P42;
p42 comprises the following raw materials in percentage by weight: 96.6% of water, 3% of kiwifruit spiny extract and 0.4% of phenoxyethanol.
7. The plant massage cream for soothing and nourishing bodies as claimed in claim 1, wherein the P4 phase further comprises the following raw materials in parts by weight: 2-5 parts of P43;
the P43 comprises the following raw materials in percentage by weight: 3.5 percent of rhodiola root extract, 10 percent of butanediol, 0.5 percent of p-hydroxyacetophenone and 86 percent of water.
8. The plant massage cream for soothing and nourishing bodies according to claim 1, wherein the P4 phase further comprises the following raw materials in parts by weight: 0.1-1 part of P44;
p44 comprises the following raw materials in percentage by weight: 3.5% of an extract of the vegetarian fanghua, 10% of butanediol, 0.5% of p-hydroxyacetophenone and 86% of water.
9. The plant massage cream for soothing and nourishing bodies as claimed in claim 1, wherein the P4 phase further comprises the following raw materials in parts by weight: 0.1-1 part of P45;
p45 comprises the following raw materials in percentage by weight: 3.5 percent of carob fruit extract, 10 percent of butanediol, 86 percent of water and 0.5 percent of p-hydroxyacetophenone.
10. The plant massage cream for soothing and nourishing bodies as claimed in claim 1, wherein the P4 phase further comprises the following raw materials in parts by weight: 0.15-0.5 part of P46;
p46 comprises the following raw materials in percentage by weight: 50% of butanediol, 38% of water, 5% of centella asiatica extract, 2% of polygonum cuspidatum root extract, 2% of scutellaria baicalensis root extract, 1% of tea extract, 1% of glycyrrhiza glabra root extract, 0.5% of chamomile flower extract and 0.5% of rosemary leaf extract.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202210758679.5A CN115414303A (en) | 2022-06-29 | 2022-06-29 | Plant massage cream capable of relaxing and nourishing body |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202210758679.5A CN115414303A (en) | 2022-06-29 | 2022-06-29 | Plant massage cream capable of relaxing and nourishing body |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN115414303A true CN115414303A (en) | 2022-12-02 |
Family
ID=84196241
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202210758679.5A Pending CN115414303A (en) | 2022-06-29 | 2022-06-29 | Plant massage cream capable of relaxing and nourishing body |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN115414303A (en) |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20150297504A1 (en) * | 2012-12-11 | 2015-10-22 | Jean-Marie Botto | Cosmetic use of a carob seed extract as a slimming active agent |
| CN107582496A (en) * | 2016-07-08 | 2018-01-16 | 南通蛇类治疗研究所 | Strong skin fat-reducing spot-eliminating beauty treatment massage cream |
| CN114652628A (en) * | 2022-03-30 | 2022-06-24 | 广州腾麟生物科技有限公司 | Anti-aging cream for beautifying chest and body and enhancing skin immune barrier and preparation method thereof |
-
2022
- 2022-06-29 CN CN202210758679.5A patent/CN115414303A/en active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20150297504A1 (en) * | 2012-12-11 | 2015-10-22 | Jean-Marie Botto | Cosmetic use of a carob seed extract as a slimming active agent |
| CN107582496A (en) * | 2016-07-08 | 2018-01-16 | 南通蛇类治疗研究所 | Strong skin fat-reducing spot-eliminating beauty treatment massage cream |
| CN114652628A (en) * | 2022-03-30 | 2022-06-24 | 广州腾麟生物科技有限公司 | Anti-aging cream for beautifying chest and body and enhancing skin immune barrier and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN105616283B (en) | A kind of plant essence restorative facial cream | |
| Aburjai et al. | Plants used in cosmetics | |
| CN104825351B (en) | A kind of Lignum Aquilariae Resinatum whitening cleansing facial milk containing and preparation method thereof | |
| KR101373636B1 (en) | Composition for improving condition of skin and scalp containing fermented extracts of herb mixture | |
| CN108670943A (en) | A kind of moisturizing, whitening, light spot composition of plant extracts | |
| CN108553389A (en) | A kind of plant moisturizing after-sun frost and preparation method thereof | |
| CN102113987B (en) | Cosmetic containing natural plant extractives and preparation method thereof | |
| CN109662928A (en) | A kind of skin care compositions and its application and preparation method with sun-proof reparation effect | |
| KR101206998B1 (en) | The scalp care composition for preventing depilation and improvement of hair growth and the hair products using the composition | |
| CN107937176A (en) | A kind of high-efficiency antioxidant anti-acne handmade soap | |
| KR20080002279A (en) | Lip cosmetic composition for atopy skin | |
| KR20180137101A (en) | Cosmetic composition for skin massaging | |
| CN109055048A (en) | A kind of pure natural moisturizing anti-acne handmade soap and its preparation method and application | |
| CN108685769A (en) | A kind of herbal mixture black hair anticreep shampoo and preparation method thereof | |
| CN111529450A (en) | Deep moisturizing repair composition, skin care product and preparation method thereof | |
| US20040191208A1 (en) | Cosmetic composition for men's skin care and hair care | |
| CN107184483A (en) | High penetration camellia massage essential oil promoting blood circulation and removing obstruction in channels and preparation method thereof | |
| KR101332215B1 (en) | Cosmetic composition containing fermentated complex of extracts with cryptomeria japonica and nelumbo nucifera for acne improvement and enhancing immune system | |
| KR102611063B1 (en) | Massage cream composition and method for manufacturing the same. | |
| KR20220168132A (en) | Composition for skin containing pine bark extract having edema relief, cellulite reduction and whitening effects, and skin cream using the same | |
| KR102102041B1 (en) | Cosmetic composition for skin soothing containing complex extracts of Hamamelis virginiana, Centella asiatica and Boswellia serrata resin, and mask-pack comprising the same | |
| CN111228154A (en) | Fresh wheat extract protoplasm milk for infants and preparation method thereof | |
| KR100979143B1 (en) | Cosmetic composition containing herb extract for skin moisturizing effect and for enhancing skin elasticity | |
| CN110974775A (en) | Allergy-relieving composition containing nostoc sphaeroides and preparation method and application thereof | |
| CN102872240A (en) | Compound essential oil for relaxing and activating collaterals |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20221202 |
|
| RJ01 | Rejection of invention patent application after publication |